What’a really interesting, though, are their reasons. They want to organize a conference to debate the issues:

“We recognize that we and the rest of the scientific community need to clearly explain the benefits of this important research and the measures taken to minimize its possible risks. We propose to do so in an international forum in which the scientific community comes together to discuss and debate these issues.”

Why is that reason interesting? It’s interesting because it seems, at least, to assume that all that is required in order to quell the public’s unease over avian flu transmission studies is for the public to near clear explanations of “the benefits of this important research.”

Now, that may well be the case. But surely not all criticisms have come from the scientifically uninformed. And there are are issues at play, here, beyond a full inventory of costs and benefits. Don’t get me wrong: I actually think this research probably needs to be done. So in fact I’m generally in agreement with the authors of this new declaration, both regarding the work and the pause. Where we differ (at least judging by this new statement) is in the content of the discussion that needs to be held. We need a discussion that at least raises the full range of relevant ethical factors, including yes costs and benefits, but also risk tolerance, rights and duties, trust, and more.

That, essentially, is the question posed by recent research into how bird flu could be made more deadly. Understanding the process is clearly useful to scientists who want to learn how better to combat deadly viruses. But it could also be useful to others with less noble goals.

From the Stanford Daily: Flu research sparks debate over censorship

Researchers successfully created a version of the H5N1 virus, typically only virulent in wild waterfowl, which could possibly be transmitted to humans.

The National Science Advisory Board for Biosecurity (NSABB) was set up after 9/11 to monitor the scientific community for bioterrorist threats. This is the first time the board has recommended authors not publish parts of an article since its inception in 2004, recommending scientists redact portions of the article which contain the methodology of how to replicate the procedure….

Final note: the problems posed by such research become more and more salient as the basic tools of biotech become cheaper and more readily available.

(See also, from The Economist: Flu Research: A Deadly Balance.)

See this article, by Andrew Pollack for the NYT: U.S. Approves Genetically Modified Alfalfa

Agriculture Secretary Tom Vilsack announced on Thursday that he would authorize the unrestricted commercial cultivation of genetically modified alfalfa, setting aside a controversial compromise that had generated stiff opposition….

Interestingly, some described this approval — the successful passing of a product through a regulatory process — as “deregulation” of GM alfalfa. For example, the Cornucopia News had this headline: BREAKING NEWS: USDA to Fully Deregulate Monsanto’s Genetically Engineer Alfalfa — Gene Contamination of Feed, Milk, Meat and Other Products to Follow…

USDA Secretary Tom Vilsack announced this afternoon that the agency will fully deregulate Monsanto’s controversial genetically engineered alfalfa. The choice was favored by the biotech industry and one of three options identified in the USDA’s Final Environmental Impact Statement (FEIS) released last month….

A new analysis presented to Congress yesterday paints a stark picture for the Defense Department’s current efforts to secure renewable fuels.

Fuels made from plant waste or algae will not be achievable in large or cheap enough quantities to make sense for military applications in the next decade, concluded the report penned by the RAND Corporation….

The rush to biofuels seems to have been a case in which good intentions have resulted in promoting “green” solutions that turn out to be mirages.

See “A win for Bill C-474: NDP secures extended debate on GE crops in January,” by Lucy Sharratt

For the first time, Parliament is engaged in a real debate over the negative impacts of genetically engineered (GE) food and crops (also known as genetically modified, GM). This debate is thanks to the one-line Private Members Bill C-474, which would require “an analysis of potential harm to export markets be conducted before the sale of any new genetically engineered seed is permitted.”

Despite industry attempts to prevent the debate from happening in the first place and a successful move to shut down Agriculture Committee hearings on the Bill, Bill C-474 continues to force more debate in both the House of Commons and the Agriculture Committee.

The Bill identifies the core problem of GE crops being approved in Canada despite predicted negative economic impacts….

See also “The Importance of Bill C-474″, by Joyce Nelson, at the Canadian Centre for Policy Alternatives.

(For some technical details, see the Bill C-474 page at OpenParliament.ca.)

It’s interesting to note that the articles above are trumpeting C-474 as an important anti-GM step, even though all the bill calls for is a strictly economic analysis.

From National Geographic, see the Self-Cloning Lizard.

According to National Geo,

…the newfound Leiolepis ngovantrii is no run-of-the-mill reptile—the all-female species reproduces via cloning, without the need for male lizards.

Since so many people apparently think cloning is unethical (typically because it is “unnatural”), surely we must conclude that this reptile, too, is unethical?

(And yes, I’m joking about the lizard being unethical. But the lizard itself, apparently, is real.)

The president’s bioethics commission says there is no need to temporarily halt research or to impose new regulations on the controversial new field known as synthetic biology.

In a report being issued Thursday, the Presidential Commission for the Study of Bioethical Issues says that at present the technology — which involves creating novel organisms through the synthesis and manipulation of DNA — poses few risks because it is still in its infancy….

A few key points:

• Self-regulation by biologists is a key recommendation. Good idea, but the details will matter a lot. Science, unlike law & medicine, are not licensed professions. That makes meaningful self-regulation harder.
• The Report also features a recommendation that scientists in this field receive training in ethics. As an ethics educator, it’s easy for me to cheer for that one. But it’s not immediately clear to me that the kinds of worries that feature prominently in criticisms of synthetic biology — ecological damage, bio-terrorism, etc. — are ones that can meaningfully be dealt with this way.
• It’s not surprising that opponents of syn-bio have been harshly critical of the Report. On the other hand, the lavish praise heaped on the report by BIO (Biotechnology Industry Organization) worries me somewhat…it makes me worry that the recommendations for regulatory oversight are not as challenging to industry as they might be. In the abstract, I would have liked to see a set of recommendations that BIO saw as tough but fair, instead of as “reasonable, well balanced and insightful.”

The Scientist spoke with chair Amy Gutmann, president of the University of Pennsylvania, about the commission’s conclusions that, despite the potential risks of creating synthetic organisms, the research should be allowed to continue.

The interview provides a good primer on the ethical issues. I’ll just point out one interesting bit. Near the start, Gutmann says:

Given that it’s a very new field, there is an opportunity to ensure that as it develops, its benefits for the public are maximized and its risk, correspondingly, minimized.

Without the benefits, no risks are worth taking. So we have to begin with the benefits…. [emphasis added]

That sounds reasonable enough, except that — depending on how narrowly you read the word “benefits” — it seems to cut off the possibility of the pursuit of knowledge for its own sake.

By Andrew Pollack, for the NYT: U.S. Says Genes Should Not Be Eligible for Patents

Reversing a longstanding policy, the federal government said on Friday that human and other genes should not be eligible for patents because they are part of nature. The new position could have a huge impact on medicine and on the biotechnology industry.

The new position was declared in a friend-of-the-court brief filed by the Department of Justice late Friday in a case involving two human genes linked to breast and ovarian cancer….

In essence, the new position is based on the idea that genes are naturally-occurring, and hence not inventions in the sense required by patent law.

However, the government suggested such a change would have limited impact on the biotechnology industry because man-made manipulations of DNA, like methods to create genetically modified crops or gene therapies, could still be patented. Dr. James P. Evans, a professor of genetics and medicine at the University of North Carolina, who headed a government advisory task force on gene patents, called the government’s brief “a bit of a landmark, kind of a line in the sand.”

Interestingly (or at least interestingly to philosophers and law professors), this is roughly in line with a Lockean theory of property, according to which something in nature can be claimed as property only once one has ‘mixed one’s labour’ with it.

Benighted European politicians seem determined to discourage certain innovations in food technology even when the rest of the world stands as living—and eating—proof of their safety.

The European Parliament called in July for a ban on marketing foods derived from cloned animals and their offspring, and on Oct. 18 the European Commission proposed sweeping, temporary bans on animal cloning for food production. The proposal encompasses the use of cloned farm animals and the marketing of food from clones, and also create a system to trace imported genetic material such as semen and cloned embryos.

These proposals conflict with the expert opinions of the European Food Safety Authority, which has said repeatedly that with respect to food safety, there is no difference between milk and meat from conventionally bred animals and those obtained from clones and their offspring….

I’ll only add that the vast majority of people simply have no idea what a clone really is. And that’s a shame. Because whether the topic is human cloning or cloning animals for food, a little misunderstanding goes a long way. And it really doesn’t take much understanding to correct quite a few ethical errors. I’m not a scientist, but every year in my Critical Thinking class I spend about 120 seconds teaching my students the basics of the laboratory cloning process. That’s all it takes.

If you think this topic is important, do yourself a favour and at least read up on the basics. To that end, here’s the Wikipedia page on cloning.